| Dec'17 | Dec'16 | Dec'15 | ||||
|---|---|---|---|---|---|---|
Operating expenses: | ||||||
Research and development | ||||||
39,341 | 32,149 | 13,587 | ||||
General and administrative | ||||||
12,049 | 6,380 | 2,762 | ||||
Loss from operations | ||||||
-51,391 | -38,529 | -16,349 | ||||
Interest income | ||||||
527 | 403 | 5 | ||||
Changes in fair value of warrants | ||||||
-200 | 1,920 | 1,980 | ||||
Other income | ||||||
933 | 2,533 | 341 | ||||
Other expense | ||||||
403 | 0 | 38 | ||||
Loss before income tax and share of loss from equity method investment | ||||||
-50,134 | -37,512 | -18,021 | ||||
Income tax expense | ||||||
0 | - | - | ||||
Share of loss from equity method investment | ||||||
-249 | - | - | ||||
Net loss | ||||||
-50,384 | -37,512 | -18,021 | ||||
Net loss attributable to ordinary shareholders | ||||||
-50,384 | -37,512 | -18,021 | ||||
Loss per share - basic and diluted | ||||||
-2.32 | -3.97 | -2.07 | ||||
Weighted-average shares used in calculating net loss per ordinary share - basic and diluted | ||||||
21,752 | 9,439 | 8,693 | ||||